Multiple sclerosis: Stem cell therapy shows promise in trial
An early clinical trial looking at stem cell therapy for progressive multiple sclerosis suggests that it could halt the progression of motor disability and cognitive impairment.
Stay updated with breaking news from Stem Cell Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An early clinical trial looking at stem cell therapy for progressive multiple sclerosis suggests that it could halt the progression of motor disability and cognitive impairment.
Although predictive tools to identify those at risk of disease progression are in their infancy, the development of such tools is crucial for improving patient outcomes.
Physicians may need to rethink maintenance with lenalidomide (Revlimid and generics) for multiple myeloma.
The experimental stem cell therapy showed promising results, with no serious side effects, in a small, one-year study.
Recent data has raised expectations that using stem cells, the body’s “master cells”, might help diminish this damage. | Health